Shaun Chandna, D.O.
NPI 1497989719ActiveIndividual· Internal Medicine, Transplant Hepatology· Salt Lake City, UT
Internal Medicine, Transplant Hepatology (D.O.) in Salt Lake City, Utah, licensed in UT, OH and WA, with an NPI issued in May 2009. Their prescriptions cost Medicare Part D more than their services did: $183,301 for 272 claims, against $2,266 paid for services in 2024. Madrigal Pharmaceuticals was the largest of 8 companies reporting payments in 2025, $48,136 in all, mostly speaking and faculty fees.
Overview
| NPI | 1497989719 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | D.O. |
| Sole proprietor | Yes |
| NPI issued | May 14, 2009 |
| Last updated in NPPES | Nov 12, 2021 |
| Certified by provider | Nov 12, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Transplant Hepatology Primary | 207RT0003X | 10552711-1204 | UT |
| Internal Medicine | 207R00000X | 34.010554 | OH |
| Internal Medicine, Gastroenterology | 207RG0100X | OP60636579 | WA |
| Internal Medicine | 207R00000X | OP60636579 | WA |
| Internal Medicine, Gastroenterology | 207RG0100X | 34 010554 | OH |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Gastroenterology (UT) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 20 |
|---|---|
| Services billed | 30 across 10 procedure codes |
| Paid by Medicare | $2,266 |
Part D prescriptions in 2024
| Prescriptions (claims) | 272 · 431 30-day fills |
|---|---|
| Patients | 79 |
| Total drug cost | $183,301 |
| Generic share | 82% of claims |
Industry payments (Open Payments)
- 2025$48,136 · 69 payments from 8 companies
- 2024$549.68 · 5 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Madrigal Pharmaceuticals | $37,055 | 44 |
| Mirum Pharmaceuticals, Inc. | $7,013 | 14 |
| Ipsen Biopharmaceuticals, Inc | $3,286 | 2 |
| Gilead Sciences, Inc. | $334.08 | 4 |
| Alnylam Pharmaceuticals Inc. | $247.99 | 2 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$35,067 · 9 payments
- Consulting Fee$6,168 · 2 payments
- Food and Beverage$3,822 · 41 payments
- Travel and Lodging$3,002 · 15 payments
- Education$78.49 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Transplant Hepatology providers in Salt Lake City
- 1619909314
- 1649282542
All Internal Medicine, Transplant Hepatology providers in Utah →